Year: 2015
Type: editorial
Abstract: The overlap between chronic obstructive pulmonary disease (COPD) and bronchiectasis is a neglected area of research, and it is not covered by guidelines for clinical practice. Here, we provide a position statement from the BRONCH-UK Consortium that is intended to be of interest to both clinicians and researchers. While we are making recommendations based on expert consensus, one of our aims is to provoke debate. Through discussion of COPD–bronchiectasis overlap, we also aim to promote research in the area, driving improvements in patient care. COPD and bronchiectasis may co-exist as an overlap syndrome <http://ow.ly/DeeE6> Other members of the BRONCH-UK Consortium include D. Bilton (Royal Brompton Hospital, London, UK), J. Bradley (University of Ulster, Belfast, UK), J.S. Brown (University College London, London, UK), F. Copeland (Primary Ciliary Dyskinesia Patient Support Group, UK), J. Duckers (University Hospital of Wales, Cardiff, UK), R.A. Floto (University of Cambridge, Cambridge, UK), J. Foweraker (Papworth Hospital, Papworth, UK), C. Haworth (Cambridge Centre for Lung Infection, Papworth, UK), A.T. Hill (Royal Infirmary of Edinburgh, Edinburgh, UK), R. Hubbard (University of Nottingham, Nottingham, UK), M.R. Loebinger (Royal Brompton Hospital, London, UK), A. McGuire (London School of Economics and Political Science, London, UK), C.R. Muirhead (University of Newcastle, Newcastle, UK), V. Navaratnam (University of Nottingham, Nottingham, UK), A. Sullivan (University Hospitals Birmingham, Birmingham UK), T.M. Wilkinson (University of Southampton, Southampton, UK) and C. Winstanley (University of Liverpool, Liverpool, UK).
Source: European Respiratory Journal
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2068880214
